首页> 美国卫生研究院文献>International Medical Case Reports Journal >Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)

【2h】

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)

机译：挑战性临床案件 - 通过0.19mg Fluocolone丙酮烯植入物（ILUVIEN®）治疗糖尿病黄斑水肿后的术治疗术治疗术治疗术治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

There are limited published data regarding the use of supplemental intravitreal therapies in patients with diabetic macular edema (DME) following treatment with the 0.19 mg fluocinolone acetonide (FAc; ILUVIEN®) intravitreal implant. The aim of this report was to analyze five challenging eyes that required supplemental therapies after treatment with the FAc implant.

机译：在用0.19mg Fluocolone醋酸乙烯酰胺（FAC;ILUVIEN®）玻璃体植入物后，有限地存在有关糖尿病黄斑水肿（DME）患者补充玻璃体内疗法的有限数据。本报告的目的是分析五个挑战性的眼睛，在用FAC植入物处理后需要补充疗法。

著录项

期刊名称 International Medical Case Reports Journal
作者
Bernardete Pessoa; João Melo-Beirão; Angelina Meireles; Pedro Menéres;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 12
原文格式 PDF
正文语种
中图分类
关键词

机译：抗VEGF;糖尿病黄斑水肿;氟氨基醇醋酸盐植入物;Ranibizumab;补充疗法;

相似文献

外文文献
中文文献
专利

1. Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN?) [J] . Bernardete Pessoa, Jo?o Melo-Beir?o, Angelina Meireles, International Medical Case Reports Journal . 2020,第3期

机译：挑战性临床案件 - 通过0.19mg氟氨酮丙酮烯植入物（ILUVIEN？）治疗糖尿病黄斑水肿后，通过玻璃体芦荟菌治疗的术治疗术治疗
2. Iluvien (TM) (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review (vol 7, pg 293, 2018) [J] . Progress in Artificial Intelligence . 2020,第1期

机译：Iluvien（TM）（Fluocinolone丙酮酮0.19毫克含有术术植入物）治疗糖尿病Marumare水肿：评论（Vol 7，PG 293,2018）
3. Iluvien? (Fluocinolone Acetonide 0.19?mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review [J] . William Fusi-Rubiano, Rebecca R. Blow, Mark Lane, Ophthalmology and therapy. . 2018,第2期

机译：伊鲁维安？氟诺龙乙酰丙酮0.19mg玻璃体内植入物治疗糖尿病性黄斑水肿的研究进展
4. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
5. Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review [O] . William Fusi-Rubiano, Rebecca R. Blow, Mark Lane, 2020

机译：校正至：Iluvien™（氟西诺酮乙酰丙酮0.19 mg玻璃体内植入物）治疗糖尿病性黄斑水肿：综述
6. >Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®) [O] . Bernardete Pessoa, João Melo-Beirão, Angelina Meireles, 2020

机译：挑战性临床案件 - 通过0.19mg Fluocolone丙酮胺植入物（ILUVIEN®）的糖尿病性黄斑水肿治疗术治疗术治疗术治疗术治疗的术治疗

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)

摘要

著录项

相似文献

相关主题

期刊订阅